Skin ulcers: an increasingly frequent plague.

The ultimate frontier in non-invasive treatment is THEAL Therapy.

Painful, chronic and disabling, are the skin ulcers that plague millions of Italians and tens of millions of people in all the world and that can now be cured with THEAL Therapy, which allows you to get them better already from the first session.
Venous, bedsores and diabetic: they are the skin ulcers, chronic lesions that invalidate in Italy two million people and tens of million of people in all the world and that are due to a failure process of epithelization. The wounds therefore do not heal because it lacks the surrounding tissue and their progress, especially for the chronic ones, is more than 8-10 weeks.
According to studies carried out by the AIUC (Associazione Italiana Ulcere Cutanee Onlus), the percentages of patients suffering from chronic skin lesions speak clearly: bedsores affect about 8% of hospital patients and between 15% and 25% of those who are hospitalized in the structure used for the long-term stay. Specifically, the lower limb ulcers are 1% in the general population with a peak of 3.6% in the population over 65 years old and belonging to a lower middle class.
For their care comes an innovative technique: THEAL Therapy (Temperature controlled High Energy Adjustable multi-mode emission Laser), the laser with modulated energy and thermo control, point of arrival after years of research, technology and innovation that has established a new standard in the industry.
“Usually the ulcers in the Charcot foot are not particularly painful. There are, however, a very large number of cases in which the patient comes to the doctor not so much for the ulcer as for the pain. Particularly effective in the treatment of this type of neuropathic is the modulated and thermo-controlled energy laser light of THEAL Therapy. In addition, THEAL Therapy, thanks to the possibility of mixing 4 different wavelengths, allows to obtain an excellent photochemical effect of tissue regeneration, essential for the treatment of skin ulcers.“
Dr. Casale - Scientific Director of Habilita and manager of Fibromyalgia ambulatory Habilita Poliambulatorio San Marco Bergamo.
Given the increasing amount of patients suffering from disabling skin ulcers, as reported by the ISTAT report according to which the Italian over 80 years old population will pass from the current 2.9 to 7.7 million by 2030, THEAL Therapy represents the new frontier to heal well and quickly with no side effects. In fact, numerous scientific research has shown the efficacy of laser light and in particular of laser light in the range 630nm – 670nm in the treatment of skin ulcers.
THEAL therapy, unlike other devices equipped with laser technology, allows you to provide 2W to 650nm and to mix other wavelengths such as 810nm, 980nm and 1064nm in order to personalize the therapy. Moreover, thanks to the possibility to modulate the emission and to control thermally the temperature of the biological tissues during the therapy it is possible to maximize the photochemical effect to promote and accelerate the tissue regeneration.
The results obtained with THEAL Therapy in the treatment of skin ulcers are excellent, perceptible since the first session and without any kind of side effect. THEAL Therapy is a fundamental ally in wound care and, thanks to the ability to modulate the energy of light and to control it thermally, it allows to obtain excellent results also in the treatment of multiple musculoskeletal pathologies. So a solution that would solve a huge problem for the elderly but also for those suffering from skin diseases and diabetes forced to long stays in hospital structures, with consequent growth in the cost of managing the patient.
In fact, in economic terms the treatment of skin ulcers involves a not indifferent costs: according to the English THIN-The Health Improvement Network report drawn up between 2012 and 2013, the management of the injuries from the economic point of view is around to 4-5.1 billion pounds per annum, expenditure comparable to the budget spent to combat obesity and more generally represents 4% of the total costs of the health system of Great Britain.